A randomized trial in Canada finds that COVID-19 patients in the audit and feedback group had lower antibiotic use but similar outcomes to patients treated with standard of care.
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies show.
Deaths and struggling health systems are among ongoing concerns, and the group will likely meet again in 3 months to reassess developments.
Infectious disease information from CIDRAP.
COVID-19 discussion & analysis on the latest developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and COVID-19 podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
“I don’t think we have a real sense of what variants to be concerned about and which not to be."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
Study says most long-COVID symptoms resolve by 1 year after mild cases, but experts not so sure
Many long-COVID patients have reported facing skepticism when seeking relief at their doctor's office.